Search
Eli Lilly and Co
LLYAdd to Watchlist
1364.730USD
-53.260-3.76%
Close 11-05 16:00（ET）
1.28TMarket Cap
48.49P/E TTM
After-hours 19:59 (ET)1366.760USD-2.510-0.18%
After-hours 19:59 (ET)Eli Lilly and Co (LLY) Stock Price Target & Forecast
Analyst Rating
Based on 33 analysts giving stock ratings to Eli Lilly and Co in the past month.
Buy
10 Strong Buy
19 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
1404.183USD-0.94%
LLY Analyst Recommendation Trends
In the current month, LLY has received 19 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. LLY average Analyst price target in the last month is 1404.183.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
10
10
10
10
10
10
11
11
19
19
17
17
18
17
16
16
3
3
6
6
6
7
7
8
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
33
33
34
34
35
35
35
35
LLY Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
AbbVie Inc
ABBV
8
18
6
0
0
32
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Regeneron Pharmaceuticals Inc
REGN
6
15
9
0
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, LLY EPS is projected to reach 11.175 in FY2026Q4, following reported EPS of 7.233 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
6.66
6.01
6.26
11.17
10.93
Actual
8.27
7.95
7.23
--
--
Surprise
+24.09%
+32.37%
+15.55%
--
--
FAQs
What is Eli Lilly and Co's expected revenue for the next quarter?
Eli Lilly and Co's expected revenue is 24.60B.
What is Eli Lilly and Co's price target?
Analysts forecast that Eli Lilly and Co's price target is USD 1.40K, with the highest forecast at USD 1.65K and the lowest forecast at USD 891.22.
How have Eli Lilly and CoLLY's recent earnings per share performed?
The market expectation was USD 7.23, while Eli Lilly and CoLLY's earnings per share (EPS) for the previous quarter was USD 7.95. EPS for the next quarter is expected at USD 11.17.
What is the analyst rating for Eli Lilly and Co?
Based on the ratings of Eli Lilly and Co's stock from 33 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.